Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Adaptimmune Therapeutics plc
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-01-31
Sale
2023-01-31
9:02 pm
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
11,890$1.8696$22,23019,535
(Direct)
View
2023-01-17
Sale
2023-01-17
9:17 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
4,440$1.858$8,2507,264
(Direct)
View
2023-01-17
Sale
2023-01-17
9:17 pm
Adaptimmune Therapeutics PLCADAPBertrand William C JR
Chief Operating Officer
4,440$1.858$8,2507,264
(Direct)
View
2023-01-17
Sale
2023-01-17
9:16 pm
Adaptimmune Therapeutics PLCADAPNorry Elliot
Chief Medical Officer
2,159$1.858$4,0113,491
(Direct)
View
2023-01-17
Sale
2023-01-17
9:15 pm
Adaptimmune Therapeutics PLCADAPRawcliffe Adrian
Chief Executive Officer
10,057$1.858$18,68613,351
(Direct)
View
2023-01-11
Sale
2023-01-12
9:03 pm
Adaptimmune Therapeutics PLCADAPBertrand William C JR
Chief Operating Officer
8,816$1.7238$15,1978,121
(Direct)
View
2023-01-11
Sale
2023-01-12
9:02 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
8,816$1.7238$15,1978,121
(Direct)
View
2023-01-11
Sale
2023-01-12
9:01 pm
Adaptimmune Therapeutics PLCADAPNorry Elliot
Chief Medical Officer
11,292$1.7199$19,42112,191
(Direct)
View
2023-01-11
Sale
2023-01-12
9:00 pm
Adaptimmune Therapeutics PLCADAPRawcliffe Adrian
Chief Executive Officer
31,805$1.7227$54,79124,882
(Direct)
View
2023-01-04
Sale
2023-01-04
9:02 pm
Adaptimmune Therapeutics PLCADAPBertrand William C JR
Chief Operating Officer
3,584$1.694$6,0715,781
(Direct)
View
2023-01-04
Sale
2023-01-04
9:01 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,100$1.694$1,8631,725
(Direct)
View
2023-01-04
Sale
2023-01-04
9:01 pm
Adaptimmune Therapeutics PLCADAPNorry Elliot
Chief Medical Officer
876$1.694$1,4841,361
(Direct)
View
2023-01-04
Sale
2023-01-04
9:00 pm
Adaptimmune Therapeutics PLCADAPRawcliffe Adrian
Chief Executive Officer
5,073$1.694$8,5946,631
(Direct)
View
2022-09-01
Sale
2022-09-01
9:00 pm
Adaptimmune Therapeutics PLCADAPRawcliffe Adrian
Chief Executive Officer
2,536$1.9689$4,9933,316
(Direct)
View
2022-08-01
Sale
2022-08-01
9:01 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
2,983$1.7735$5,2904,829
(Direct)
View
2022-08-01
Sale
2022-08-01
9:00 pm
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
21,040$1.7735$37,31434,824
(Direct)
View
2022-07-05
Sale
2022-07-05
9:00 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,973$1.6781$3,3113,104
(Direct)
View
2022-06-27
Sale
2022-06-27
9:01 pm
Adaptimmune Therapeutics PLCADAPRawcliffe Adrian
Chief Executive Officer
2,562$1.63$4,1763,290
(Direct)
View
2022-05-20
Purchase
2022-05-23
9:00 pm
Adaptimmune Therapeutics PLCADAPWood Gavin
Chief Financial Officer
39,000$0.2904$11,32696,000
(Direct)
View
2022-01-18
Sale
2022-01-18
9:04 pm
Adaptimmune Therapeutics PLCADAPBertrand William C JR
Chief Operating Officer
4,368$3.1918$13,9427,336
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-17
Option Award
2023-01-17
9:07 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPBertrand William C JR
Chief Operating Officer
1,924,128$01,924,128
(Direct)
View
2023-01-17
Option Award
2023-01-17
9:06 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,912,248$01,912,248
(Direct)
View
2023-01-17
Option Award
2023-01-17
9:05 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPBrewer Joanna Elizabeth
Chief Scientific Officer
1,856,808$01,856,808
(Direct)
View
2023-01-17
Option Award
2023-01-17
9:04 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPTAYTON-MARTIN HELEN KATRINA
Chief Business & Strgy Officer
1,918,392$01,918,392
(Direct)
View
2023-01-17
Option Award
2023-01-17
9:04 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPWood Gavin
Chief Financial Officer
1,915,056$01,915,056
(Direct)
View
2023-01-17
Option Award
2023-01-17
9:03 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPNorry Elliot
Chief Medical Officer
1,914,672$01,914,672
(Direct)
View
2023-01-17
Option Award
2023-01-17
9:02 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
1,902,888$01,902,888
(Direct)
View
2023-01-17
Option Award
2023-01-17
9:01 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPRawcliffe Adrian
Chief Executive Officer
6,488,496$06,488,496
(Direct)
View
2022-07-01
Option Award
2022-07-01
5:18 pm
2023-07-01
2032-07-01
Adaptimmune Therapeutics PLCADAPBehbahani Ali
Director
737,050$0737,050
(Direct)
View
2022-07-01
Option Award
2022-07-01
5:03 pm
2023-07-01
2032-07-01
Adaptimmune Therapeutics PLCADAPZaks Tal Zvi
Director
500,000$0500,000
(Direct)
View
2022-07-01
Option Award
2022-07-01
5:03 pm
2023-07-01
2032-07-01
Adaptimmune Therapeutics PLCADAPAlleva Lawrence M
Director
816,067$0816,067
(Direct)
View
2022-07-01
Option Award
2022-07-01
5:02 pm
2023-07-01
2032-07-01
Adaptimmune Therapeutics PLCADAPFurey John
Director
500,000$0500,000
(Direct)
View
2022-07-01
Option Award
2022-07-01
5:02 pm
2023-07-01
2032-07-01
Adaptimmune Therapeutics PLCADAPNoble James
Director
710,711$0710,711
(Direct)
View
2022-07-01
Option Award
2022-07-01
5:01 pm
2023-07-01
2032-07-02
Adaptimmune Therapeutics PLCADAPSigal Charles Elliott
Director
737,050$0737,050
(Direct)
View
2022-07-01
Option Award
2022-07-01
5:01 pm
2023-07-01
2032-07-01
Adaptimmune Therapeutics PLCADAPDuncan Barbara Gayle
Director
500,000$0500,000
(Direct)
View
2022-07-01
Option Award
2022-07-01
5:00 pm
2023-07-01
2032-07-01
Adaptimmune Therapeutics PLCADAPMOTT DAVID M
Director
1,000,439$01,000,439
(Direct)
View
2022-05-04
Option Award
2022-05-04
9:03 pm
N/A
2032-05-04
Adaptimmune Therapeutics PLCADAPBrewer Joanna Elizabeth
Chief Scientific Officer
557,304$0557,304
(Direct)
View
2022-01-31
Option Award
2022-01-31
9:05 pm
N/A
2032-01-31
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
4,466,376$04,466,376
(Direct)
View
Goto 0, 1, 2, 3, 4, Next